Viewing Study NCT00017069


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-25 @ 8:19 PM
Study NCT ID: NCT00017069
Status: TERMINATED
Last Update Posted: 2020-10-05
First Post: 2001-06-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
Sponsor: CTI BioPharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module